The Host's Immune Responses Against Viruses: How We Know Our Own Bodies and How Our Bodies Defend Themselves from Viruses

Authors

• Eman A. Muhsin, Research and Technology Center of Environment, Water and Renewable Energy. Scientific Research Commission, Ministry of Higher Education and Scientific Research; Baghdad, Iraq 11001Follow
• Neyaf Majid Alageedi, Department of Biology , University of Diyala; 32001 Diyala city, Iraq
• Shahrazad Ahmed Khalaf, Department of Forensic science , University of Diyala; 32001 Diyala city, Iraq)

Abstract

Background: Viral infections pose a significant threat to health worldwide, requiring a coordinated and effective immune response to limit and eventually eliminate viral infection. The purpose of this review is to examine the different ways by which the immune system responds, both by innate and adaptive pathways, against viral infections, along with the mechanisms by which viruses evade host immune responses.

Method: A systematic literature review was performed with an organized search through the following databases; PubMed, Scopus, Web of Science and ScienceDirect. The search was for studies published between 2015-2025. The final number of included articles was 45 as determined by established inclusion/exclusion criteria.

Outcomes: The research results suggest that innate immunity is the first line of defense and that recognition patterns are detected by pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and RIG-I like receptors (RLRs) resulting in the creation of Type I interferons and activation of antiviral- pathways. Adaptive immunity provides a more specific immune response via Cytotoxic T Cell (CTL), Helper T Cells (TH) and Antibody producing B Cells. Notwithstanding these immune responses, many viruses have evolved to evade detection with numerous methods, including antigenic variation, immune suppression and latency.

In conclusion, host immune responses during a viral infection involve many different and complex interactions between all of the different components of the immune system. Understanding host immunity and immune system interactions during a viral infection is critical for developing effective vaccines and antiviral therapies. There is also a need for further research into the development of immunotherapies and targeting the virus' ability to escape from host immune defenses.

Recommended Citation

Muhsin, Eman A.; Alageedi, Neyaf Majid; and Khalaf, Shahrazad Ahmed (2026) "The Host's Immune Responses Against Viruses: How We Know Our Own Bodies and How Our Bodies Defend Themselves from Viruses," Maaen Journal for Medical Sciences: Vol. 5 : Iss. 2 , Article 5.
Available at: https://doi.org/10.55810/2789-9136.1098

References

[1] Medina KL. Overview of the immune system. InHandbook of clinical neurology 2016 Jan 1 (Vol. 133, pp. 61-76). Elsevier.

[2] Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW. Principles of Virology. fourth ed. 2015.

[3] Howley PM, Knipe DM, Enquist LW. Fields Virology: Fundamentals. Lippincott Williams & Wilkins; 2023 Feb 14.

[4] World Health Organization. Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2022—2030: Report on Progress and Gaps 2024. World Health Organization; 2024 May 21. Available from: https://www.who.int.

[5] Murphy K, Weaver C. Janeway's immunobiology. Garland science 2016 Mar 1.

[6] Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol 2014 Jan;14(1):36—49.

[7] Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. science 2011 Jan 7;331(6013):44—9.

[8] Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004 Jun 1;78(11):5535—45.

[9] Gibbert K, Schlaak JF, Yang D, Dittmer U. IFN-α subtypes: distinct biological activities in anti-viral therapy. Br J Pharmacol 2013 Mar;168(5):1048—58.

[10] Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 2015 Aug;15(8):486—99.

[11] Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 2010 Oct;10(10): 699—711.

[12] Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008 May;9(5): 503—10.

[13] Franchi L, Munoz-Planillo ~ R, Núnez ~ G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012 Apr;13(4):325—32.

[14] Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 2012 Oct 18;12(4):396—407.

[15] Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998 Dec 21;188(12):2205—13.

[16] Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev 1992 Mar;56(1):152—79.

[17] Gale Jr M, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005 Aug 18;436(7053):939—45.

[18] Speck SH, Ganem D. Viral latency and its regulation: lessons from the γ-herpesviruses. Cell Host Microbe 2010 Jul 22;8(1):100—15.

[19] Douek DC, Roederer M, Koup RA. Emerging concepts in the immunopathogenesis of AIDS. Annu Rev Med 2009 Feb 18;60(1):471—84.

[20] Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015 Apr;16(4): 343—53.

[21] Newton, A.H., Cardani, A. and Braciale, T.J., 2016, July. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. In Semin Immunopathol (Vol. 38, No. 4, pp. 471-482). Berlin/Heidelberg: Springer Berlin Heidelberg.

[22] Park A, Iwasaki A. Type I and type III interferons—induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe 2020 Jun 10;27(6):870—8.

[23] Mehand MS, Millett P, Al-Shorbaji F, Roth C, Kieny MP, Murgue B. World health organization methodology to prioritize emerging infectious diseases in need of research and development. Emerg Infect Dis 2018 Sep;24(9):e171427.

[24] Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2―preliminary report. N Engl J Med 2020 Nov 12;383(20):1920—31.

[25] Murphy K, Weaver C. Janeway's immunobiology. Garland science 2016 Mar 1.

[26] Iwasaki A, Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol 2015 Apr;16(4): 343—53.

[27] Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9(5): 503—10.

[28] Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010 Apr 23;28(1): 445—89.

[29] Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, et al. A blueprint for HIV vaccine discovery. Cell Host Microbe 2012 Oct 18;12(4):396—407.

[30] Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 2013 Jul; 19(7):859—68.

[31] Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021 Feb 18;184(4):861—80.

[32] Abed RE, Salman AN, Issa AH, Al-Salih M. Evaluation of the level of IL-2 in the HCV patients in the thi qar province southern Iraq. InAIP Conference Proceedings 2023 Sep 13 (Vol. 2845, No. 1, p. 020017). AIP Publishing LLC.

[33] Khalaf SA. Serum level of some immunological markers in COVID-19 patients in Diyala province, Iraq. Iraqi Emerg Med 2024;10(4):329—33.

[34] Gambadauro A, Galletta F, Li Pomi A, Manti S, Piedimonte G. Immune response to respiratory viral infections. Int J Mol Sci 2024 Jan;25(11):6178.

[35] Khalaf SA, Alloul S, Muhsin EA, Khalaf QA. Detection of the serum levels of some immunological parameters in patients with HBV. Mag Al-Kufa Univ Biol 2024;16(1).

[36] Abid IA, Latif II, Ghaab NF, Jadoo SA. Lymphocyte, IL-10, IL-6, and IFN-g cytokines modulation in SARS-CoV-2 patients. Journal of Angiotherapy 2024 Apr 6;8(4):1—8.

[37] Kadhim HJ, Shlaga AK, Ali SH. Clinical and molecular identification of Newcastle disease virus in naturally infected chicks in thi-qar province of Iraq. Open Vet J 2024 Nov 30;14(11):2817.

[38] Kadhim HA, Slama FB. Interleukin-17 gene polymorphisms and hepatitis B virus infection in a sample of Iraqi patients. SOUTH EASTERN EUROPEAN JOURNAL OF PUBLIC HEALTH 2024:692—5.

[39] Al-Jizani AS, Al-Ubaidi AE, Khassaf SA, Al-Jaryan EA. Investigating the potential of IL-17 in chronic HBV infection. Iraqi Journal of Medical Sciences 2024 Jun 30;22(1).

[40] Talib AL, Kadhim HS. The role of soluble immune checkpoint in SARS-CoV-2 Iraqi patients. Iraqi Journal of Medical Sciences 2024 Dec 22;22(2).

[41] Woodcock A, Bergin R, Kedia-Mehta N, Foley C, Stephens JC, O'Shea D, et al. Obesity drives dysregulation in DC responses to viral infection. Discovery Immunology 2025;4(1). kyaf001.

[42] Staples KJ. Asthma, change is the only constant. Am J Respir Crit Care Med 2025 Feb;211(2):141—2.

[43] Al-Maliki L, Issa YW, Salih SM, Hassan SA, Hassoon HJ. Expression profiles of HLA-G, HLA-H and HLA-F post SARS-CoV2 vaccination and infection in Iraq. Cuestiones de Fisioterapia 2024 Jun 10;53(2):242—8.

[44] Alqahtani AM. Mucosal immunity in COVID-19: a comprehensive review. Front Immunol 2024;15:841532. https://doi.org/10.3389/fimmu.2022.841532.

[45] Kasuga Y, Zhu B, Jang KJ, Yoo JS. Innate immune sensing of coronavirus and viral evasion strategies. Exp Mol Med 2021 May;53(5):723—36.

[46] Rahman MA, Gelanew T, Barman S, Nainu F. Vaccineinduced innate immunity and its role in viral infections. Front Immunol 2024 Jul 11;15:1440061.

[47] Yang OO. The immunopathogenesis of SARS-CoV-2 infection: overview of lessons learned in the first 5 years. J Immunol 2025 Jun;214(6):1095—104.

[48] Wang Z, Cheng F, Xu Y, Li X, Meng S. Role of innate immunity in SARS-CoV-2 infection. Biosafety and Health 2023 Oct 25;5(5):280—8.